Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses

PLoS One. 2014 Sep 29;9(9):e108798. doi: 10.1371/journal.pone.0108798. eCollection 2014.

Abstract

Background: Natural killer (NK) cells provide defense in the early stages of the immune response against viral infections. Killer cell immunoglobulin-like receptors (KIR) expressed on the surface of NK cells play an important role in regulating NK cell response through recognition of human leukocyte antigen (HLA) class I molecules on target cells. Previous studies have shown that specific KIR/ligand combinations are associated with the outcome of several viral infectious diseases.

Methods: We investigated the impact of inhibitory and activating KIR and their HLA-class I ligand genotype on the susceptibility to Chikungunya virus (CHIKV) and Dengue virus (DENV2) infections. From April to July 2010 in Gabon, a large outbreak of CHIKV and DENV2 concomitantly occurred in two provinces of Gabon (Ogooué-Lolo and Haut-Ogooué). We performed the genotypic analysis of KIR in the combination with their cognate HLA-class I ligands in 73 CHIKV and 55 DENV2 adult cases, compared with 54 healthy individuals.

Results: We found in CHIV-infected patients that KIR2DL1 and KIR2DS5 are significantly increased and decreased respectively, as compared to DENV2+ patients and healthy donors. The combination of KIR2DL1 and its cognate HLA-C2 ligand was significantly associated with the susceptibility to CHIKV infection. In contrast, no other inhibitory KIR-HLA pairs showed an association with the two mosquito-borne arboviruses.

Conclusion: These observations are strongly suggestive that the NK cell repertoire shaped by the KIR2DL1:HLA-C2 interaction facilitate specific infection by CHIKV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Chikungunya Fever / immunology*
  • Chikungunya Fever / virology
  • Chikungunya virus / immunology*
  • Dengue / genetics
  • Dengue / immunology*
  • Dengue / virology
  • Dengue Virus / immunology*
  • Female
  • Gabon
  • Gene Frequency / genetics
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Genetic Variation
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Ligands
  • Male
  • Receptors, KIR / genetics*

Substances

  • Histocompatibility Antigens Class I
  • Ligands
  • Receptors, KIR

Grants and funding

This study was funded in part by the Institut National de la Recherche Médicale (INSERM), and the Université Pierre et Marie Curie, Paris, France. Vincent Vieillard is a researcher from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.